News for Your Practice
Expert Commentary
Daily reporting from the 2021 Society of Gynecologic Surgeons Annual Meeting
SGS Fellow Scholar Jenna Rehmer, MD, provides daily coverage from Palm Springs, CA
Dr. Rehmer is from the Department of...
News for Your Practice
Prophylactic antibiotics for myomectomy?
ACOG does not currently recommend antibiotics for myomectomy procedures. A retrospective study adds to the evidence, however,...
Expert Commentary
Respiratory particles generated by speech can remain airborne for up to 14 minutes
News for Your Practice
ACOG offers guidance on optimizing patient care in the midst of COVID-19
News for Your Practice
Prenatal exposure to pollutants consumed through diet found to be associated with decreased fetal growth
Even low levels of exposure to persistent organic pollutant mixtures may reduce fetal growth, say researchers
Ideally,...
News for Your Practice
Is elagolix effective at reducing HMB for women with varying fibroid sizes and types?
Yes, according to data from phase 3 trials
Whether or not women experience symptoms from uterine fibroid(s) can be...
News for Your Practice
What does the REPLENISH trial reveal about E2/P4’s ability to affect VMS and sleep and appropriate dosing for smokers?
Compared with placebo, women taking E2/P4 experienced reduced VMS frequency and severity and improved sleep
The REPLENISH...
News for Your Practice
Postmenopausal women would benefit from clinician-initiated discussion of GSM symptoms
Almost 20% of postmenopausal women wished that their practitioner had addressed their vulvovaginal health in a discussion at...
Article
ObGyn compensation: Strides in the gender wage gap indicate closure possible
While male physicians’ earnings remained stagnant, female physicians’ earnings increased 2%. And if you think the largest cities...
News for Your Practice
Are ObGyns knowledgeable about the risk factors for hepatitis C virus in pregnancy?
OBG Manag. 2019 May;31(5)
While nearly 78% of survey respondents said that they screen pregnant patients for HCV...
News for Your Practice
Is elagolix safely effective at reducing heavy uterine bleeding in premenopausal women with uterine fibroids?
Phase 3 data showed that elagolix, plus low-dose add-back hormone therapy, reduced heavy menstrual bleeding at 6 months in 68.5%...